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INTRODUCTION
Dysfunctional  uterine  bleeding  is  one  of  the  most  frequently 
encountered conditions in gynaecologic practice and forms about 10% of all  
gynaecological admissions.
In  Government  Raja  Sir.  Ramasamy  Mudaliar  (RSRM)  Lying  –  In 
Hospital  in the year  2006-2008,  700 cases of the 2000 admissions in the 
Department of Gynaecology were for dysfunctional uterine bleeding giving an 
incidence of 20% of these.
5% - less than 20 years (Pubertal age group)
60% - between 20-40 years (Reproductive age group)
35% - more than 40 years (perimenopausal and 
postmenopausal)
The main concern in perimenopausal bleeding and post menopausal 
bleeding is that the bleeding could be the only external manifestation of a 
hidden serious pathology such as endometrial carcinoma. Also, endometrial 
hyperplasia which is a fore runner of endometrial  carcinoma is a common 
finding in women with perimenopausal bleeding. 
The incidence of  endometrial  carcinoma is  rising both in relation to 
cancer  cervix  and in  absolute  terms and the  disease which  was  formerly 
confined  to  the  postmenopausal  women  is  now  occurring  with  increased 
frequency in middle age and perimenopausal women. Also with the advent of 
hormone  replacement  therapy  postmenopausal  women  require  constant 
surveillance of their endometrium.
Curettage has long been considered to be the “Gold Standard” for the 
diagnosis of perimenopausal and post menopausal uterine bleeding.
Dilatation  and  curettage  has  a  failure  rate  of  12-30%.  Undirected 
sampling either through curettage or suction aspiration is fraught with error in 
cases, in which the abnormality is not global, but focal.
With  advent  of  transvaginal  sonogram,  Gynaecologist  now  have  a 
simple outpatient  method of studying  endometrium for detecting malignant 
lesion or their precursors at an earlier stage.
The thickness  and internal  echo  texture  of  the  endometrium in  the 
various  phases  of  menstrual  cycle  as  seen  in  transvaginal  sonogram 
correlates well with endometrial histology.
The echogenicity of the endometrium has certain characteristics during 
various  phases  of  the  menstrual  cycle,  thus  enabling  the  histology  to  be 
evaluated with precision by examining with transvaginal sonogram
During the early proliferative phase the endometrial thickness is 2-4mm. 
Endometrium  functionalis  is  hypoechoic  or  isoechoic  and  endometrium 
basalis echogenic.
During the periovulatory phase the endometrium, has trilaminar appearance or 
triple sign-lumen is echogenic surrounding which there is hypoechoic endometrium 
functionalis and the echogenic endometrium basalis. The thickness ranges from 6-
12mm.
During secretory phase, the whole endometrium from basalis to lumen is very 
echogenic.  The greatest thickness is achieved during secretory phase measuring 
upto 14mm in width.
In postmenopausal  patients, thickness less than 4-5mm or thin pencil  line 
echo is usually associated with tissue insufficient for diagnosis. In general, normal 
thickness in postmenopausal patients is 4mm.
Endometrial  carcinoma  is  diagnosed  at  an  earlier  stage  by  loss  of  the 
subendometrial halo and later myometrial invasion is accurately documented.
Other pathologic  conditions of  the endometrium and myometrium such as 
myomatous polyps, endometrial polyps, adenomyosis are also well visualised.
Thus  with  transvaginal  sonogram  the  endometrial  pathology  can  be 
visualised, where as fractional curettage is a blind procedure. Thus the transvaginal 
sonogram can be used as a better diagnostic procedure as it supplements the short 
comings of fractional curettage.
This study proposes to correlate the finding of the two diagnostic modalities 
used in the evaluation of women with perimenopausal and postmenopausal bleeding 
namely transvaginal sonogram and histo pathological examination.
AIM OF THE STUDY
1. To  determine  the  value  of  transvaginal  sonography  in  detecting 
endometrial pathology especially endometrial polyps, myomatous polyps and 
abnormal  endometrial  architecture especially hyperplasias and endometrial 
carcinoma in perimenopausal and postmenopausal bleeding.
2. To  compare  the  thickness  of  endometrium  in  patients  with 
perimenopausal  and  postmenopausal  bleeding  with  their  histopathology 
reports  and evaluate  the  technical  and practical  difficulties  and diagnostic 
accuracy of the procedure.
MATERIALS AND METHODS
This is a prospective study of 200 women carried out during the period 
2006-2008 – A hundred women with postmenopausal bleeding and a hundred 
women with perimenopausal bleeding.
GROUP A : Comprised of 100 women with postmenopausal bleeding.
Inclusion Criteria
• Age above 40 years.
• Menopause more than 1 year.
• Not on any Hormone replacement therapy.
• No demonstrable pelvic pathology
• Clinically no mass per abdomen and bimanual pelvic examination.
• No evidence of blood dyscrasias.
Exclusion Criteria
• Patients with carcinoma cervix
• Patients on Oral contraceptive pills.
• Patients with fibroid polyp.
• Adnexal swelling
• Patients with blood dyscrasias.
Group B : Comprised of 100 perimenopausal women with abnormal uterine 
bleeding.
Selection Criteria :
• The patients were all above 40 years of age.
• Not yet attained menopause.
• Uterus  was  normal  to  12  week  size  and  adnexa  were  clinically 
normal
• On speculum examination cervix was healthy.
• Cancer cervix and other benign pathological lesions of cervix were 
excluded.
All the patients were from Government Raja Sir Ramasamy Mudaliar 
(RSRM) Lying – In Hospital, Chennai.
All these patients were subjected to transvaginal sonography prior to 
fractional curettage.
Method
A 7.5 MHz Elcot transvaginal sector probe with phased array and end 
firing potential were used.
- All  the  patients  were  asked  to  empty  their  bladder  prior  to  the 
examination.
- The probe is covered with a sterile sheath or condom containing 
the acoustic gel.
- The scan was performed with the patient in a supine position.
- The transducer was introduced into the posterior vaginal fornix.
The uterus was scanned in long axis and coronal views with special 
emphasis on endometrium. The scanning of the uterus was first done in the 
sagittal plane from fundus to the internal os. The regularity of the uterus was 
noted. The length, anteroposterior measurements and transverse dimensions 
of the uterus were noted and endometrial volume calculated.
Anteroposterior  measurements  of  endometrial  thickness  were  taken 
from basalis  to  contralateral  basalis  in  the  long axis  of  the  endometrium. 
Oblique  semicoronal  views  should  be  avoided  as  this  may  cause  the 
endometrium to appear thicker.
Uterine  cavity  examined  systematically  in  both  sagittal  and  coronal 
views  for  the  presence  of  submucous  fibroid  polyps,  endometrial  polyps, 
adenomyosis or abnormal endometrial architecture.
If there is suspicion of endometrial carcinoma, the evidence and extent 
of myometrial invasion were noted. Now the probe angled to the right or left of  
midline in the sagittal plane to image the ovaries. The three dimensions were 
measured. The internal echo texture of the ovaries were also imaged and any 
abnormalities were noted.
The  entire  pelvis  was  additionally  examined  to  rule  out  any  other 
pathology.
The results of the transvaginal sonogram were interpreted as
- Normal endometrium
- Thickened endometrial echo or abnormal endometrial architecture 
- Myomas
- Adenomyosis
- Polypoid lesions
- Pyometra
- Endometrial hyperplasia and a suspicious endometrial carcinoma.
Fractional curettage was performed in all these patients as a inpatient  
procedure.  Patients  were  placed  in  lithotomy  position.  Under  aseptic 
precautions  perineum  was  painted  and  draped.  A  routine  pervaginal 
examination carried out. Endocervical curetting was taken. Uterus was then 
sounded and its length noted. After serial dilatation of cervix, a blunt curette  
was introduced and all  quadrants curetted thoroughly.  The curettings were 
sent for histopathological examination in formalin. The biopsy reports were 
studied.
Endometrial pattern studied in transvaginal sonogram were correlated 
with  histopathological  reports.  Almost  all  of  these  patients  underwent 
hysterectomy either abdominal or vaginal.
REVIEW OF LITERATURE
History of Ultrasound
The word “SONAR” stands for Sound Navigation And Ranging. Sonar 
utilizes  a  frequency  of  3.5  MHz  to  10  MHz  beyond  the  range  of  human 
audibility limit. Ultrasound travels at a speed of 1560 m/sec in human tissue.
“Sergal  Sokolovin”  a  Russian  Scientist  is  called  as  the  “Father  of 
Ultrasound”. He emphasized the potential importance of Sonar in 1929.
Dr.Karl Dussik in Austria, applied ultrasound in medical diagnosis.
In 1951, Wild and Reig reported a 90% accuracy in the diagnosis of 
cystic versus solid lesions of various organs using the scan technique.
In 1955, Ian Donald and Tom Brown designed the contact scanner.
In 1961, Biparietal diameter was first measured by Ian Donald. During 
the same peroid, Campbell began working on the growth patterns of fetus as 
measured by serial Biparietal diameter. In 1973 – gray scale presentation was 
introduced. 
“Piezo electric effect” was first discovered by Pierre Curie in 1880.
Transvaginal ultrasound was first introduced in 1984 by Schwimer S.R. 
and Lebovic J who used a 5 MHz, 13 mm transducer that was not specifically 
designed for vaginal work.
In 1969, a total number of 6907 Dilatation and curettage were 
reviewed and the concept arrived was that the curettage was simple, 
harmless, and easy to perform, that it may be done by the newest intern 
without difficulty.  Under general anaesthesia it also provides an ideal 
opportunity for thorough examination of pelvic organs  (Mc Elin et al 
1969)1. 
With the introduction of Transvaginal sonogram, the transducer 
proximity  to  the  endometrium  with  the  absence  of  full  bladder 
compressing the endometrium, and also the usage of higher frequency 
and  reduced  attenuation  of  sound  beam  results  in  a  better  overall 
image quality. 
 Nasri et al in their comparative study between Transabdominal 
and transvaginal  sonography concluded that transvaginal  sonography 
should replace Transabdominal sonography in the initial assessment of 
gynaecological disorders (Nasri et al 1999) 2.
Lewin  et  al  showed  that  transvaginal  sonogram  can  reliably 
diagnose  endometrial  thickness  greater  than  5  mm  to  be  100% 
sensitive and 64% specific in identifying endometrial pathology. (Lewin 
et al 1996) 3.
Kufahl. J and Pedersen.I et al4 showed a sensitivity of 90.3% 
and a specificity of 24.8% for a cutoff  value of  4mm by transvaginal 
sonogram.
Malinova  M  and  Pehlivanov  et  al  adopted  the  transvaginal 
approach to increase the accuracy of diagnosis (Malinova et al 1995)5.
The ‘classification tree’  method was used to identify the cutoff 
values of sonographic endometrial thickness that could be indicative of 
a class of uterine pathology. No case of endometrial cancer was found 
with a cutoff point of 5mm endometrial thickness, whereas all patients 
with endometrial thickness more than 15mm at transvaginal sonogram 
had an endometrial carcinoma. In a group of patients with endometrial 
thickness  between  6  and  14  mm,  they  found  a  normal  atrophic 
endometrium, benign and malignant pathology. (Loverro et al 1999)6.
Ramirez et al (2001)7,  proposed that an endometrial thickness grater 
than 5mm warranted further investigation in the form of biopsy.
Transvaginal sonography is a simple non-invasive procedure. It can be 
used  as  a  screening  test  for  patients  with  perimenopausal  and 
postmenopausal bleeding (Tongsong et al 1994)8. Endometrial thickness of 
less than 7mm was found to be predictive of normal endometrium.
According  to  Osmer  et  al  (1990)9, since  all  cases  of  endometrial 
cancers were associated with an endometrial thickness of more than 4mm. It 
is the cutoff level above which an endometrial study will be mandated.
Li S, Gao S stated that the endometrial thickness of less than 4mm is 
highly unlikely to be associated with carcinoma. Diagnostic curettage may be 
avoided in patients who had endometrial thickness less than 4mm (Li S , Gao 
S et al 1997)10. 
Campbell  et  al  (1992)11 stated  that  the  endometrial  thickness less 
than 5mm is  highly  unlikely  to  be  associated  with  carcinoma where  as  a 
thickness greater than 8mm requires biopsy.
PERIMENOPAUSAL AND POSTMENOPAUSAL BLEEDING
In both Western and Asian studies the mean age of menopause is 
fairly constant at 50-51 years (Frommer 1964).
Perimenopause or menopausal transition is defined by World Health 
Organisation (WHO) as the period in the beginning 2-8 years prior to final 
menstrual period and lasting upto 12 months after the final menstrual period.
PERIMENOPAUSAL BLEEDING:
In  the  perimenopausal  women,  bleeding  begins  with  increased 
variability of menses or the first skipped period and ends with final menstrual 
period.
It comprised of an early phase in which cycles may be irregular but a 
menstrual period occurs atleast once in every 60 days and later stage, during 
which  prolonged  amenorrhoea  of  3  to  10  months  followed  by  menstrual  
bleeding is observed.
The main cause of perimenopausal bleeding include
Endometrial hyperplasia - 15-25%
Benign lesion of the uterus-myomas - 10%
Dysfunctional uterine bleeding - 15-20%
Malignancies of the reproductive tract - 10-15%
Cancer cervix - 10-12%
Cancer endometrium - 2-4%
Adenomyosis - 20-25%
Exogenous estrogen therapy - 3 -5 %
Miscellaneous causes are : - 10%
Endometrial polyps
Endometritis
Cervical polyp and erosion
 Rarely pregnancy related causes
POSTMENOPAUSAL BLEEDING
Normally  one  year  period  of  amenorrhoea  after  the  age  of  40  is 
considered as menopause. However, vaginal bleeding occurring anytime after 
six  months  of  amenorrhoea  in  women  of  menopausal  age  should  be 
considered  as  postmenopausal  bleeding  and  investigated.  Even  without 
amenorrhea  or  irregular  bleeding,  if  a  woman  over  the  age  of  52  years 
continues  to  menstruate,  she  needs  investigation  to  rule  out  endometrial 
hyperplasia  and  malignancy  of  the  genital  tract.  
(Shaw et al)12
The main causes of postmenopausal bleeding includes 
Endometrial atrophy - 60-80%
Endometrial polyps - 2-12%
Endometrial hyperplasia - 5-10%
Estrogen replacement therapy - 15-25%
Endometrial cancer – sarcoma - 10%
Cancer cervix - 10%
Atrophic vaginitis - 5-10% 
Endometrial Hyperplasia
In the perimenopausal period, the menstrual cycles tend to become 
anovulatory  and  acyclical,  with  unopposed  estrogen  secretion  leading  to 
hyperplasia of the proliferative endometrium (Kurman RJ et al 1985) 13.
Classification
Risk of progression to 
cancer (Percentage)
Simple cystic without atypia 1
Complex adenomatous without atypia 3
Simple cystic with atypia 8
Complex adenomatous with atypia 29
Fibroids  are  an  important  cause  of  perimenopausal  bleeding.  If  a 
woman in the perimenopausal and postmenopausal age group complains of 
irregular or continuous vaginal bleeding, the possibility of coincidental uterine 
cancer should be excluded.
Adenomyosis  often  coexists  with  uterine  fibromyomas  and 
endometrial carcinoma.
Endometrial  atrophy  is  the  most  common  endometrial  finding  in 
women with  postmenopausal  bleeding (60-80%).  Endometrial  biopsy often 
yields insufficient tissue or only blood clots and usually there is no additional 
bleeding after biopsy.
Endometrial polyps account for 2-12% of postmenopausal bleeding. 
The diagnosis of polyps is often missed by dilatation and curettage or office 
endometrial  biopsy.  Malignant  transformation  in  an  endometrial  polyp  is 
estimated to be as high as 0.5 - 2.7%  (Novak et al)14.  Unrecognised and 
untreated  polyps  may  be  a  source  of  continued  or  recurrent  bleeding 
eventually leading to unnecessary hysterectomy.
 They are invariably hyperechoic relative to the surrounding tissues 
and sometimes contain small cavitations.
Endometrial  cancer:  Perimenopausal  women with  endometrial  carcinoma 
invariably  have abnormal  uterine  bleeding which  is  often  characterised as 
menometrorrhagia or metropathia haemorrhagica.
Recently  certain  factors  led  to  an  increasing  awareness  of  an 
emphasis on diagnosis and treatment of endometrial cancer. These include 
prolonged  life  expectancy,  earlier  diagnosis  and  postmenopausal  use  of 
hormone replacement  therapy,  the  availability  of  easily  applied  diagnostic 
tools  and  a  clear  understanding  of  the  premalignant  lesions  of  the 
endometrium. The incidence of endometrial  carcinoma in Indian women is 
1.6% (Ratnam et al)15.
HORMONE REPLACEMENT THERAPY: 
In postmenopausal  women on hormone replacement therapy,  it  has 
been suggested that endometrial sampling is indicated in any bleeding that 
occurs beyond the expected time of withdrawal following progestin therapy. In 
patients  on  classic  sequential  method,  bleeding  before  or  on  day  ten  is 
associated  with  endometrial  proliferation  and  needs  biopsy.  A  significant 
change in withdrawal bleeding prompts endometrial sampling. ( Timmermans 
et al 2008)16.
TRANSVAGINAL SONOGRAM
Dubinsky.TJ  et  al17 has  described  that  transvaginal  sonogram  is 
preferred over biopsy because,
1. Less invasive procedure 
2. Painless
3. No complications
4. May be more sensitive for detecting carcinoma than blind biopsy.
Ultrasonography  may  also  be  used  as  a  first  line  investigation  in 
women with abnormal uterine bleeding, because it is cost effective, sensitive 
and  well  tolerated  method  in  combination  with  physical  examination  and 
endometrial biopsy.
As  the  endometrial  histology  can  be  predicted  with  accuracy 
depending  on  the  endometrial  thickness  and  internal  architecture  of  the 
endometrium, it actually became “Sono Microscopy” wherein structures that is 
not discernible with the naked eye can be appreciated.
Wolman et al 18 at Serlin Maternity Hospital in their prospective study, 
transvaginal  sonography  as  an  aid  in  determining  which  woman  with 
postmenopausal bleeding should undergo curettage or not.
Grigoriou  et  al19 were  to  determine  the  value  of  screening 
transvaginal  sonogram  for  the  evaluation  of  endometrial  abnormalities  in 
women with postmenopausal bleeding after excluding women with any pelvic 
symptoms or on hormone replacement therapy. Endovaginal ultrasound is a 
valuable diagnostic instrument as sensitive as dilatation and curettage. 
Normal anatomy of the corpus varies with age and parity. 
Length of uterus in various age groups are :
Postpubertal - 5-6 cm
Reproductive - 7-8 cm 
Postmenopausal - 4-6 cm
The echogenicity and thickness of the normal endometrium will  vary 
depending on the phase of the menstrual cycle.
The normal  endometrial  thickness during the various phases of  the 
menstrual  cycle  and  during  the  postmenopausal  period  are  given  in  the 
following table. The thickness is measured in the long axis from basalis to 
contralateral  basalis. The measurement should include only tissue and not 
fluid.
Phase Thickness (mm)
Menstrual 2-4
Early Proliferative 4-6
Periovulatory 6-8
Secretory 8-14
Postmenopausal 4-8
Postmenopausal  with  hormone  replacement 
therapy
4-10
Tissue insufficient for diagnosis Less than 4-5mm
Archer et al in 199920 has described that the endometrial thickness 
measured at the thickest part of the longitudinal plane for which the uterus 
was scanned transversely and longitudinally. Endometrial biopsy was taken 
within 3 days of transvaginal ultrasound measurements.
Not  only  the  thickness,  the  echogenicity  of  the  endometrium  has 
certain  specific  characteristics during the  various phases of  the  menstrual 
cycle, thus enabling the histology of the endometrium to be evaluated with 
precision by examining with transvaginal sonogram.
During  the  menstrual  phase,  the  endometrium  appears  as  an 
echogenic uninterrupted layer of 1-4mm in the total anteroposterior width.
A prospective study in 192 patients with postmenopausal bleeding and 
97 women without  bleeding found that  74.8% had a positive  result  which 
include  proliferative  endometrium  and  secretory  endometrium  (Gunner.et 
al1996)21. 
Grunfeld has described three patterns in evaluating the changes in the 
normal endometrium.
Follicular Phase
Pattern I : During the early proliferative phase the thickness is 2-4 mm. 
Endometrium  functionalis  is  hypoechoic  or  isoechoic  and  endometrium 
basalis is somewhat echogenic.
Pattern II  :  Ultrasound appearance of  late  follicular endometrium is 
characterized by three layers i.e. Trilaminar appearance or triple sign.
Middle layer represents the lumen of the endometrial cavity. The lumen 
is echogenic because the endometrium is coated with mucus which acts as 
an interface and reflects ultrasound.
Surrounding the lumen is the hypoechoic endometrium functionalis and 
the  echogenic  endometrium basalis.  There  is  an  increase  in  echogenicity 
from the basal layer upwards but the inner layer still has some hypoechogenic 
changes.
The  endometrium  functionalis  is  hypoechoic  in  the  follicular  phase 
because  of  the  homogenicity  of  the  oedematous  stroma  and  the  lack  of 
arteriole  invasion.  The  basalis  is  always  echogenic  because  of  increased 
edema and  vascularity  of  the  basalis.  In  a  normal  cycle,  the  endometrial 
thickness  ranges  from  6-12mm  in  the  late  follicular  phase.  Endometrium 
grows in the late proliferative phase at a rate of 0.5mm /day.
The  trilaminar  appearance  is  characteristic  of  periovulatory 
endometrium and was  present  in  92% of  late  proliferative  phase biopsies 
performed by Forrest. Transmission of the ultrasound and posterior acoustic 
enhancement are also characteristic of follicular phase and is present in 90% 
of cases.
Pattern  III  :  In  the  secretory  phase,  the  whole  endometrium  from 
basalis  to  lumen  is  very  echogenic.  The  increase  in  echogenicity,  most 
probably is due to increase in luteal phase secretions and vascularity.  The 
increase in echogenicity is seen due to the elevations of progesterone but 
may precede the rupture of follicle. Cul-de-sac fluid is often seen behind the 
uterus on ultrasound and helps to confirm that ovulation has occurred. The 
endometrium  achieves  its  greatest  width  in  the  mid  secretory  phase 
measuring upto 14mm in width.
Getpook et al (2006)22 proposed that endometrial thickness of 8mm or 
less  is  less  likely  to  be  associated  with  malignant  pathologies  in 
perimenopausal uterine bleeding.
The sensitivity  in  detecting endometrial  malignancy was 94.44% for 
endometrial  biopsy  and  100%  for  transvaginal  sonogram,  when  the 
endometrial thickness was more than 8mm.( Giusa Chiferi et al) 23
According to  Minagawa et al 2005 24 all women with atypical uterine 
bleeding for postmenopausal women with endometrial thickness more than 
5mm, and perimenopausal  women with  thickness more than 20mm is the 
cutoff level, above which an endometrial biopsy will be mandated.
Below  a  cutoff  of  4-5mm  in  the  anteroposterior  thickness  of  the 
endometrium for  women with  postmenopausal  bleeding,  there may not  be 
significant associated pathology. Less than 4-5mm or a thin pencil line echo is 
usually associated with tissue insufficient for diagnosis.
Those  more  than  5  mm  may  need  endometrial  sampling.  Thus 
transvaginal sonogram may be helpful in distinguishing patients with minimal 
endometrial  tissue  caused  by  postmenopausal  atrophy  and  patients  with 
significant amount of endometrial tissue or polyps and are in need of further 
evaluation.
PATHOLOGIC CONDITIONS
Recent studies with transvaginal ultrasound suggest that this modality 
may  be  of  use  in  detecting  endometrial  abnormalities  like  polyps, 
endometritis, hyperplasia and carcinoma.
Leiomyoma  are seen as echodense defects within the myometrium. 
They are typically so dense that shadowing is apparent distal to the fibroid. 
Endovaginal sonography offers the opportunity to visualize the relationship of 
the fibroid to the endometrial cavity.
Adenomyosis  does not  have clear borders and is less dense than 
leiomyoma.  They  do  not  have  a  shadow like  fibroids  and  are  commonly 
cystic. They are seen as mottling within the myometrium. They may present 
as a myometrial mass or as cystic structures, if the glands begin secreting 
within the inner myometrium.
Endometrial polyps are seen as endometrial filling defects. Scanning 
for  endometrial  contour  defects  should  be  done  in  the  follicular  phase 
because the hypoechoic endometrium serves to contrast against echogenic 
masses. The presence of a filling defect is 70% sensitive and 95% specific 
when compared with hysterosalphingogram (Blumen feld and Turner 1996).
Endometrial  atrophy in the postmenopausal women results in a thin 
hypoechoic  endometrium  on  transvaginal  sonography.  Abnormal  or 
suspicious endometrial pattern occurs in a thick and hyperechoic pattern.
Endometrial  hyperplasia in  postmenopausal  women appears  as  a 
thickened  hyperechoic  endometrium  with  an  intact  subendometrial  halo 
microinvasive endometrial carcinoma may have similar ultra sonic features.
Once the invasion is established, the subendometrial halo consisting of 
compact myometrium is lost.  This is the first  ultrasonic feature of invasion 
seen sonographically.
With more advance myometrial invasion a distinct tumour myometrial 
interface can be visualised.
Myometrial  invasion  may  also  produce  a  thickened  and  irregular 
central endometrial interface with echogenic or hypoechoic pattern combined 
with infiltration of hyperdense structures within the myometrium.
In an attempt to  standardize measurements of  myometrial  invasion, 
schoenfeld et al measured invasion from the endometrial lumen to the most 
distant tumour interface. This distance was then divided by the total thickness 
of the uterine myometrium, if the lumen could not be discerned, the extent of 
myometrial  invasion  was  estimated  by  dividing  the  total  anteroposterior 
uterine  distance  by  the  total  endometrial  width  myometrial  invasion  was 
suspected, if this ratio exceeded by 30%.
Transvaginal sonogram is frequently used in preoperative assessment 
of  myometrial  invasion.  In  a  group  of  25  patients  histologically  proven 
endometrial  cancer  was  determined.  Myometrial  invasion  with  ultrasound 
reported a sensitivity of 93% , when the invasion was greater than 50%. The 
diagnostic accuracy was 81%.(Prompeler et al 1994) 25.
Cacciatore et al26 used pre-operative ultrasound to stage 93 patients 
with  endometrial  cancer  and  were  able  to  predict  correctly  myometrial 
invasion in 80% sonographic staging was accurate in 91% of cases.
Endometrial and Endocervical polyps
They are invariably hyperechoic relative to the surrounding tissues and 
sometime contain small cavitations.
Intracavitory and Submucous leiomyoma
They  are  usually  hypoechoic  where  as  polyps  and  endometrial 
hyperplasia  do not  alter  the basalis  myometrial  interface,  the myoma and 
invasive cancer are characterized by the disruption of this interface.
Endometrial  Volume: An endometrial  volume can be calculated by 
multiplying  its  length  by  long  axis,  with  anteroposterior  and  transverse 
dimensions. This determination has clinical application in the prediction of the 
amount of decidua or abnormal endometrial tissue that is present and can be 
removed by dilation and curettage.
Gruboeck  et  al27 suggested  that  volume  measurement  of  the 
endometrium  are  much  more  promising  than  endometrial  thickness  in 
screening for cancer because they are more sensitive and have a greater 
positive predictive value. 
They studied 97 patients with cancer, hyperplasia, polyp and normal or  
atrophic endometrium and reported sensitivity (100 % for volume and 83% for 
thickness). Positive predictive value (92% for volume and 55% for thickness.)
Since many gynaecologist have felt the need for a simple, safe and 
noninvasive method which could be employed as a screening procedure for 
detecting  endometrial  abnormalities  and  neoplasia.  A  routine  pap  smear 
detects only 50% of cases with endometrial cancer.
Curettage has long been considered to be the gold standard for the 
diagnosis  of  perimenopausal  and  postmenopausal  uterine  bleeding.  A 
fractional curettage can provide definitive results . Larson et al28 showed that 
dilatation and curettage was significantly more accurate in identifying cancer 
and  predicting  final  grade  of  the  disease.  Still  the  false  negative  rate  of 
dilatation and curettage for the diagnosis of endometrial cancer may be as 
high as 2 to 6%.
Epstein et al29 showed that the study to compare the frequency of 
rebleeding  and  endometrial  growth  during  a  12  month  followup  period 
between woman with  postmenopausal  bleeding and endometrial  thickness 
less than 5mm managed by dilatation and curettage and those managed by 
ultrasound followup after 3, 6, and 12 months. If these women are managed 
by  ultrasound  followup  endometrial  sampling  should  be  performed  if  the 
endometrium  grows,  not  necessarily  in  the  case  of  rebleeding  without 
endometrial growth.
In women with endometrial  thickness less than 7mm, endorette and 
dilatation  and curettage showed similar  results.  In  women with  more  than 
7mm  endorette  yield  insufficient  samples  more  often  than  dilatation  and 
curettage and missed all polyps and most hyperplasia diagnosed by dilatation 
and curettage.(Epstein E, Skoog L, et al 2001)30 
Curci-C et al31 used Transvaginal sonogram and fractional explorative 
curettage and histopathological examination of the material obtained from the 
cervical canal and uterine cavity on 35 women. Transvaginal sonogram does 
not  provide  completely  safe  differentiation  between  hyperplasia  and 
endometrial  carcinoma.  Endometrial  thickness  of  3  mm and  less  gives  a 
relatively safe prediction of endometrial atrophy, whereas the thickness above 
3mm requires explorative curettage and histopathological examination of the 
endometrium, no matter if the women has or not uterine bleeding.
Rodriguez  et  al32 did  a  pathologic  study  of  25  hysterectomy 
specimens.  Pipelle’s  device  sampled  only  4% of  the  endometrial  surface. 
Vibra aspirator sampled 41% of the endometrial surface.
Thus tumours localised in a polyp or a small area of endometrium may 
go undetected by endometrial sampling or even with dilatation and curettage. 
Hence  transvaginal  sonogram  can  enhance  the  anatomic  diagnosis  and 
supplement the shortcomings of fractional curettage.
PROCEDURE OF TRANSVAGINAL SONOGRAM
Until  recently,  the  primary  method  for  detecting  gynaecological 
pathology was bimanual pelvic examination, with confirmatory or additional 
information supplemented by transabdominal ultrasound.
Despite technical advances, transabdominal ultrasound imaging of the 
female reproductive tract was limited by attenuation of the sound beam by 
tissues of the anterior abdominal wall, distended urinary bladder, precluding 
the use of high frequency transducers (5 MHz) and the inability to correlate 
areas  of  visible  pathology  with  direct  palpation.  Image  resolution  has 
improved dramatically  with  the  introduction of  transvaginal  sonogram.  The 
transducer is closer to the pelvic organs, so higher frequencies can be used, 
reducing attenuation of the sound beam resulting in improved overall image 
quality.
PATIENT PREPARATION
Patient was informed about the procedure. She is asked to empty her 
bladder  completely.  This  contributes  greatly  to  patient  comfort  and 
acceptance  of  this  technique.  The  best  position  is  the  dorsal  position 
employed for vaginal examination. A transabdominal sonogram is done prior 
to vaginal study to exclude large masses and if uterus is more than 10 cms as 
in such conditions, the vaginal study will be suboptimal due to its limited field 
of view. In all other cases, transvaginal sonogram can be performed in lieu of  
abdominal scanning.
TRANSDUCER PREPARATION
Vaginal transducer is between 5-7.5 MHz in frequency and the size of 
the sector image is usually between 900 and 1150. The image is produced 
from an end firing transducer or a transducer that is angled upto 300 off axis. 
Focal  zones range from 1-8 cm. The transducer  should be covered by a 
condom filled with approximately 5ml of ultrasonic gel. Condoms that contain 
spermicidal agents should be avoided in cases of infertility.
Additional gel may be applied to the outside of the condom prior to its 
insertion,  but  this  should  be  omitted  in  cases  of  infertility.  Following 
completion of examination, the transducer assembly should be immersed in 
disinfectant for ten minutes.
PROBE MANIPULATION
Uterine corpus is an important structure in transvaginal sonogram and 
serves  as  a  useful  anatomical  land  mark  for  targeted  organ  imaging. 
Transducer  orientation  is  unique in  vaginal  scanning,  with  the longitudinal 
plane directed from the patient’s feet towards her head. Transverse scans are 
obtained  in  a  coronal  plane  by  rotating  the  transducer  ninety  degrees 
counterclockwise. Adnexa are optimally imaged by positioning the transducer 
somewhat obliquely towards the contralateral side of the pelvis.
Confusion  can  also  occurs,  because  the  actual  position  of  the 
ultrasound beam is 900 off axis from the image on the monitor. This result in 
the longitudinal  images being displayed on the monitor in a ninety degree 
counter clockwise direction from their actual orientation.
Ultrasound  transducers  have  a  reference  mark.  With  the  reference 
mark pointing up, left  side of the screen represents a cephalad orientation 
and the top of the screen represents the anterior abdominal wall. With this 
view, an anteverted uterus points up and to the left while a retroverted uterus 
points down and to the right.
Anatomic changes due to scanning with an empty bladder must also 
be  considered  when  performing  vaginal  ultrasound.  The  uterine  fundus 
becomes much more anteverted. In addition the ovaries often change position 
following bladder decompression.
SLIDING TEST : It may be helpful to place one hand on the patient’s 
lower  abdomen  while  performing  transvaginal  sonogram  in  an  effort  to 
optimally position the ovaries in the transducer’s field of view. Also areas of 
focal  tenderness  can  be  elicited  with  the  movement  of  the  transducer. 
Transvaginal  sonogram  can  also  be  used  in  the  followup  of  women  on 
tamoxifen therapy for  breast  cancer and women on hormone replacement 
therapy after menopause.(Weaver et al 2005) 33.
 Omodei  et  al  (2004) 34 also  stated  that  the  value  of  endometrial 
thickness as a marker of endometrial abnormality during hormone therapy by 
transvaginal sonography between day 5 and day 10 after the drug intake.
RESULTS
GROUP  A  =  100  WOMEN  WITH  POST  MENOPAUSAL 
BLEEDING
TABLE – 1: 
AGE – DISTRIBUTION OF POSTMENOPAUSAL PATIENTS
Age of Patient
Number of 
patients
Percentage
Cumulative 
percentage
45 – 50 years 52 52.0 52.0
51 – 55 years 24 24.0 76.0
56 – 60 years 18 18.0 94.0
More than 60 years 6 6.0 100.0
Total 100 100.0
Note : Half of the patients in the study belong to 45-50 years of age group.
TABLE – 2 : 
PARITY DISTRIBUTION OF POSTMENOPAUSAL WOMEN WITH 
BLEEDING IN STUDY GROUP.
Age of Patient
Number of 
patients
Percentage
Cumulative 
percentage
Less than P - 2 30 30.0 30.0
Between P 3-4 38 38.0 68.0
More than P - 5 32 32.0 100.0
Total 100 100.0
TABLE – 3
DURATION OF MENOPAUSE:
Duration in years
Number of 
patients
Percentage
Cumulative 
percentage
Less than 3 50 50.0 50.0
Between 3-5 18 18.0 68.0
Between 5-7 14 14.0 82.0
Between 7-9 6 6.0 88.0
More than 9 12 12.0 100.0
Total 100 100.0
Note: 50% of the women have postmenopausal bleeding with in 3 years of 
attaining menopause.
TABLE – 4
ASSOCIATED MEDICAL CONDITIONS:
Medical conditions
Number of 
patients
Percentage
Cumulative 
percentage
Anaemia 4 4.0 4.0
Diabetes 8 8.0 12.0
Hypertension 6 6.0 18.0
Normal 82 82.0 100.0
Total 100 100.0
Note :  8% of  women with  postmenopausal  bleeding had diabetes mellitus 
during the study period.
TABLE – 5
ASSOCIATED FINDINGS IN TRANSVAGINAL SONOGRAM
Associated findings
Number of 
patients
Percentage
Cumulative 
percentage
Normal 78 78.0 78.0
Pyometra 10 10.0 88.0
Polyp 4 4.0 92.0
Fibroid 2 2.0 94.0
Endometrial abnormalities 6 6.0 100.0
Total 100 100.0
Note: 10% of women had associated pyometra and only 4% of women had 
associated polyp.
TABLE – 6
ENDOMETRIAL THICKNESS BY USING TRANSVAGINAL SONOGRAM
Endometrial thickness
Number of 
patients
Percentage
Cumulative 
percentage
Less than 5 mm 52 52.0 52.0
More than 5 mm 48 48.0 100.0
Total 100 100.0
Note:  48  %  of  women  with  postmenopausal  bleeding  had  a  endometrial 
thickness of more than 5mm
TABLE – 7
Comparison of histopathology (Fractional Curettage) with 
vaginosonographic measurement of endometrial thickness in
Group A - Women with Post menopausal bleeding.
Histopathology
Report
Mean 
endometrial 
thickness in 
mm
Number 
of 
patients
Percentage
Cumulative 
percentage
Atrophic 
endometrium
3.75 (2-5) 42 42.0 42.0
Tissue insufficient 
for  diagnosis 
(TIFD)
3.2 (1.2-5) 10 10.0 52.0
Cystoglandular 
hyperplasia
12.2 (10-14) 10 10.0 62.0
Complex 
hyperplasia
13 (13-14) 2 2.0 64.0
Nonsecretory
endometrium
7.7 (6-8) 12 12.0 76.0
Secretory 
endometrium
8.75 (8-10) 8 8.0 84.0
Pyometra/ 
Endometritis
8.5 (8-10) 10 10.0 94.0
Endometrial 
carcinoma
16.7 (16-18) 6 6.0 100.0
Total 100 100.0
Note : 
 52% of women with Atrophic endometrium or TIFD had a mean 
endometrial  thickness less than 5 mm and 48% of  patients with 
endometrial pathology had a thickness more than 5 mm.
 42%  of  women  had  atrophic  endometrium  with  a  mean 
endometrial  thickness  of  3.75  mm.  10%  of  patients  had  tissue 
insufficient  for  diagnosis  with  a  mean  endometrial  thickness  of 
3.2mm.
The  incidence  of  endometrial  hyperplasia  was  12%  with  a  mean 
endometrial  thickness  of  12.2mm.  The  incidence  of  nonsecretory 
endometrium was 14% with a mean endometrial thickness of 7.7 mm. The 
incidence  of  secretory  endometrium  was  8%  with  a  mean  endometrial 
thickness  of  8.75mm.  In  5  cases  of  pyometra,  the  mean  endometrial 
thickness was 8.5 mm. 6% of cases had endometrial carcinoma with a mean 
endometrial thickness of 16.7mm.
Thus it can be seen that 52% of women with atrophic endometrium or 
tissue insufficient for diagnosis had a mean endometrial thickness less than 
5mm and 48% of  patients  with  endometrial  pathology namely proliferative 
phase, hyperplasia, carcinoma of the endometrium and pyometra had a mean 
endometrial thickness more than 5mm.
This is comparable with the following studies.
(i) Narsi and associates at St. Bartholomew’s hospital studies 111 women 
with  postmenopausal  bleeding –  results  were  published in  obstetric 
and gynaecologic surgery 1991.
51 patients (45.9%) had normal ultrasound findings and endometrial 
thickness  was  1-5  mm.  The  remaining  54.1%  of  patients  had  an 
endometrial thickness of more than or equal to 6 mm. In 11 patients 
(10%) ultrasound findings were suggestive of hyperplasia. In 6 women 
ultrasound  correctly  predicted  carcinoma  of  endometrium.  In  16 
patients  fibroids  were  diagnosed.  Narsi  et  al suggested  that  an 
endometrial thickness of 5mm or less is associated with endometrial 
atrophy and curettage is unnecessary in this group.
(ii)  Mahlinova and Pehlivanov conducted a prospective study of one 118 
patients with postmenopausal bleeding. They compared transvaginal 
sonogram  and  endometrial  thickness  to  histopathological  reports  in 
these women. (Published in the European Journal  of  obstetrics and 
gynaecology 1995 February).
In  47.0%  of  women  with  histopathological  diagnosis  of  atrophic 
endometrium  the  mean  endometrial  thickness  was  3.1  + 1.7  mm 
whereas  in  the  remaining  53%  of  women  with  endometrial 
abnormalities  the  endometrial  thickness  ranged  from  10.2mm.  The 
mean endometrial  thickness for patients with  endometrial  carcinoma 
was 18.4 + 8.2mm.
No  endometrial  carcinoma  was  diagnosed  in  endometrial  thickness 
less than or equal to 5mm. The sensitivity was 100% and specificity 64% if a 
cutoff of 5mm was used.
TABLE – 8
Comparison of ultrasonographic findings with histopathologic 
diagnosis of fractional curettage and hysterectomy specimen in women 
with postmenopausal bleeding.
Ultrasonographic
findings
Number of 
patients
FC – HPE 
report Hysterectomy HPE report
Thin distinct 
pencil line echo
less than or  equal 
to 5mm
52 10-TIFD
42-Atrophic 
endometrium
10- Atrophic endometrium
38- Atrophic endometrium
4 – Lost for followup
Endometrial 
thickness  more 
than
5 mm
26 6-C.G.H
2-C.H
10-N.S.E.
8-S.E
6-C.G.H.
2-C.H.
10-N.S.E.
8- S.E.
Fibroid 2 Fibroid
Not diagnosed
2-C.G.H.
2- 2 x 2.0 cm anterior 
wall fibroid
Endometrial 
carcinoma
6 6-endometrial 
carcinoma
2 - Fibroid anterior wall 
2x2  cm  seen  in  association 
with endometrial carcinoma 
4- well differentiated 
adenocarcinoma. Grade-I 
Myometrial invasion less than 
1/3
Endometrial Polyp 4 2-N.S.E.
2- C.G.H
Polyp  not 
diagnosed
An endometrial  polyp  1x1  cm 
seen. 
2- N.S.E.
2 – C.G.H.
Pyometra 10 10-Pus  letout 
and 
endometritis
4 – Endometritis
2 – Atrophic endometrium
2 – Secretory endometrium 
2 – Lost for follow-up
TIFD - Tissue Insufficient for Diagnosis
C.G.H - Cysto Glandular Hyperplasia
N.S.E - Non Secretory Endometrium
S.E - Secretory Endometrium
F.C. - Fractional Curettage
C.H. - Complex Hyperplasia
Note : The findings of the transvaginal sonogram correlated well with 
the final histopathologic diagnosis after hysterectomy giving a 
sensitivity of 92.31% and specificity of 67.57%. There were no 
false negative and false positive findings. Fractional Curettage 
missed 3 fibroid polyps and one endometrial polyp.
In  52  patients  transvaginal  sonogram  showed  that  an  endometrial 
thickness of less than or equal to 5 mm and the histopathology report after 
hysterectomy report was atrophic endometrium. Endometrial abnormality was 
suggested in  the  remaining  48 cases.  In  these 48 patients,  there  were  2 
cases  of  fibroid,  4  case  of  endometrial  polyp,  6  cases  of  endometrial 
carcinoma, 10 cases of pyometra, 26 cases with endometrial echo more than 
5mm were associated with endometrial hyperplasia including two cases with 
complex  hyperplasia  with  or  without  atypia.  All  these  patients  underwent 
hysterectomy and the histopathology findings of the hysterectomy specimen 
correlated well with the findings of transvaginal sonogram giving a sensitivity 
of 92.31% and specificity of 67.57%.
The  findings  of  the  present  study  are  comparable  with  that  of  the 
following studies (i) Dubinsky TJ, Parvey HR and Maklad N has evaluated 
with role of transvaginal sonography and endometrial biopsy in the evaluation 
of  postmenopausal  bleeding  published  in  the  American  Journal  of 
Roentgenology 1996 July.
They  have  evaluated  the  reliability  of  transvaginal  sonogram  in 
diagnosing intrauterine disease by comparing it with hysterectomy specimen. 
In 259 women transvaginal sonogram was done. 
The findings were 
 Endometrial thickness less than or equal to 5mm in 107 women.
 Endometrial thickness of more than 5mm in 39 women. 
 Enlarged uterus in 64 women.
 Endometrial carcinoma in 18 women.
Final pathologic diagnosis were
 Atrophic endometrium in 107 women.
 Endometrial hyperplasia in 39 women.
 Endometrial carcinoma in 18 women with enlarged uterus.
 Fibroids in 57 women.
 Adenomyosis in 3 women.
 Sarcoma in 4 women.
In  their  study  the  correlation  between  transvaginal  sonogram  and 
histopathological  report  of  hysterectomy  specimen  was  very  accurate  in 
yielding sensitivity of 96%, specificity of 86%, positive predictive value of 91% 
and negative predictive value of 94%.
(ii) Weber in their study of transvaginal sonogram in 28 women with 
postmenopausal bleeding found that 14 patients had normal sonogram with 
an endometrial  thickness less than or equal  to  5mm and 14 patients had 
endometrial  thickness  more  than  or  equal  to  5  mm  with  endometrial 
abnormalities.  All  these  patients  underwent  hysterectomy  and  findings 
correlated with a transvaginal sonogram giving sensitivity of 94%, specificity 
of  48%, positive  predictive  value  of  69% and negative  predictive  value  of 
89%.
GROUP- B: 100 WOMEN WITH PERIMENOPAUSAL BLEEDING
TABLE – 1:
AGE – DISTRIBUTION OF PERIMENOPAUSAL WOMEN WITH BLEEDING 
IN A STUDY GROUP
Age of Patient
Number of 
patients
Percentage
Cumulative 
percentage
41 – 45 years 64 64.0 64.0
46 – 50 years 28 28.0 92.0
51 – 55 years 8 8.0 100.0
Total 100 100.0
Note  :  More  than  60%  of  the  patients  in  the  study  group  belongs  to  
41-45 years of age.
TABLE – 2 :
PARITY DISTRIBUTION IN THE PERIMENOPAUSAL STUDY GROUP.
Age of Patient
Number of 
patients
Percentage
Cumulative 
percentage
Less than P - 2 28 28.0 28.0
Between P 3-4 60 60.0 88.0
More than P - 5 12 12.0 100.0
Total 100 100.0
Note : More than half of the patients in the study group between para 3 and 
para 4.
TABLE – 3
ASSOCIATED MEDICAL CONDITION
Medical conditions
Number of 
patients
Percentage
Cumulative 
percentage
Anaemia 16 16.0 16.0
Hypertension 10 10.0 26.0
Normal 74 74.0 100.0
Total 100 100.0
Note :  Anaemia was the most  common medical  condition associated with 
perimenopausal women with bleeding in a study group (16%)
TABLE – 4
ASSOCIATED FINDING IN TRANSVAGINAL SONOGRAM
Associated pelvic findings
Number of 
patients
Percentage
Cumulative 
percentage
Adenomyosis 16 16.0 16.0
Myomatous polyp. 14 14.0 30.0
Ovarian cyst. 6 6.0 36.0
Endometrial polyp. 4 4.0 40.0
Endometrial abnormalities 2 2.0 42.0
Normal 58 58.0 100.0
Total 100 100.0
Note : 16% of perimenopausal women have an associated adenomyosis and 
only 4% of endometrial polyp. 
TABLE – 5
ENDOMETRIAL THICKNESS BY USING TRANSVAGINAL SONOGRAM
Endometrial thickness
Number of 
patients
Percentage
Cumulative 
percentage
Less than 15 mm 74 74.0 74.0
Between 15 - 25 mm 24 24.0 98.0
More than 25 mm 2 2.0 100.0
Total 100 100.0
Note:  Only  2%  perimenopausal  women  with  bleeding  had  endometrial 
thickness more than 25mm
TABLE – 6
 Comparison of histopathology with vaginosonographic measurement 
of endometrial thickness in perimenopausal group.
Histopathology
Report
Mean 
endometrial 
thickness in 
mm
Number 
of 
patients
Percentage
Cumulative 
percentage
Nonsecretory 
endometrium
8.4 (5-10) 60 60.0 60.0
Secretory 
endometrium
10.8 (10-13) 12 12.0 72.0
Cystoglandular
hyperplasia
17.1(16-19) 20 20.0 92.0
Adenomatous 
hyperplasia
20 2 2.0 94.0
Atypical hyperplasia 23 2 2.0 96.0
Endometritis 11 2 2.0 98.0
Endometrial 
carcinoma
27 2 2.0 100.0
Total 100 100.0
Note : With an endometrial thickness less than or equal to 15mm the 
histopathology  report  is  normal  endometrium.  When  the 
endometrial  thickness  more  than  or  equal  to  15mm  the 
histopathology report is hyperplasia or carcinoma.
In this group, those with a nonsecretory endometrium have a mean 
endometrial  thickness of  8.4mm, with  secretory endometrium of  10.8 mm, 
with  cystoglandular  hyperplasia  of  17.1mm, with  adenomatous hyperplasia 
the  thickness  was  20  mm,  with  atypical  hyperplasia  was  23  mm,  with 
endometritis was 11mm and with endometrial carcinoma was 27mm.
72 cases (72%) of women with perimenopausal bleeding had normal 
endometrium  by  transvaginal  sonogram  and  had  a  mean  endometrial 
thickness  of  8.8mm  with  a  range  of  5-13mm.  For  all  these  patients  the 
histopathological  report  was  either  nonsecretory endometrium or  secretory 
endometrium.
In  the  remaining  28 cases (28%) with  endometrial  abnormality,  the 
endometrial  thickness  was  found  to  range  from  16mm  in  a  case  with 
cystoglandular hyperplasia to 23 mm for atypical hyperplasia to 27 mm for a 
case with endometrial carcinoma.
Therefore it can be seen that below an endometrial stripe thickness 
less  than  or  equal  to  15mm  the  histopathology  report  was  normal 
endometrium  either  secretory  or  non  secretory.  An  endometrial  stripe 
thickness more than or equal to 15mm has been found to be associated with  
hyperplasia including one adenomatous and one atypical hyperplasia. 
The results of this present study are compared with the results of the 
following study.
(i) Emmanuel, Mark, Marion, Verdel and Lammes in the American Journal 
of Obstetrics and gynaecology have determined the diagnostic value of 
transvaginal sonogram for endometrial and intrauterine abnormalities 
in women with perimenopausal bleeding.
In  279  consecutive  perimenopausal  women  with  abnormal  uterine 
bleeding were  subjected to  transvaginal  sonogram. Though a cutoff 
value  for  endometrial  thickness  in  premenopausal  patients  is  not 
available in the literature, they have found that in their study population 
a cutoff level of 12 mm for normal premenopausal endometrium was 
adequate with no false negative or false positive results.
135 patients with normal sonogram were confirmed to be true negative 
by  histopathological  examination.  The  mean  thickness  of  the 
endometrium was 5.8 + 2.8mm (range 1-12 mm). Abnormal sonogram 
found in 121 patients had a mean thickness of 
14.3  +2.3mm  (range  13-20  mm).  The  “thinnest”  endometrial 
hyperplasia was found to be 13mm. With these findings a cutoff level  
of  12mm was found to  be adequate in this study population with  a 
sensitivity and specificity of 100%.
(ii) Towbi, Gnazda March published in the American Journal of obstetrics 
and  gynaecology  June  1996,  examined  131  patients  with 
perimenopausal bleeding by transvaginal sonogram. As the maximum 
thickness of the endometrium is 14mm an endometrial echo complex is 
considered thickened if it is more than or equal to 15mm.
They  have  found  that  a  thickened  endometrial  stripe  more  than  or 
equal to 15mm is a better predictor of intracavitory pathologic disorders 
in  the  follicular  phase  than  in  the  luteal  phase.  59  patients  had  a 
normal sonogram with endometrial stripe less than or equal to 15mm. 
Rest  of  the  patients  had  endometrial  stripe  more  than  or  equal  to 
15mm. Of these 6 patients with endometrial stripe more than or equal 
to  15mm with  no other  structural  abnormalities were  found to  have 
hyperplasia of endometrium. 52 patients had Ultrasonography results 
consistent with leiomyomas 11 had thickened uterine wall and 2 had 
polypoid lesion. No case of endometrial carcinoma was reported.
Hence they have suggested that a thick endometrial echo complex in 
the follicular phase more than or equal to 15mm correlates strongly with the 
presence of intracavitory pathologic disorders and endometrial abnormalities.
The results of this study are found to be comparable with that of the 
present study.
TABLE – 7
Comparison of transvaginal sonographic findings with histopathologic 
diagnosis of fractional curettage and hysterectomy in women with 
perimenopausal bleeding
Ultrasonographic
findings
Number
of patients
FC – HPE report
Hysterectomy HPE 
report
Normal 
endometrium 
thickness less than 
or equal to 15 mm
50 38-N.S.E.
12-S.E
28-N.S.E.
6-S.E
16- followed up with 
Transvaginal sonogram
Endometrial 
thickness  more 
than or equal to 
15 mm
12 10-C.G.H
2-Adenomatous
 hyperplasia
10-C.G.H
2-Adenomatous
 hyperplasia
Adenomyosis 16 8-N.S.E.
8- C.G.H
16 - Adenomyosis
Myomatous polyp 14 10-N.S.E.
2- C.G.H
2 – Atypical 
 hyperplasia
10-N.S.E.
2- C.G.H
2 – Atypical 
 hyperplasia
Endometrial Polyp 4 4-N.S.E. 4 - Endometrial Polyp 
with N.S.E.
Endometritis 2 2- Endometritis 2– Endometritis
Endometrial 
carcinoma
2 2-Adenocarcinoma 2 – lost for followup
Note : Findings  of  transvaginal  sonogram  correlated  well  with 
histopathological  report  after  hysterectomy.  16  cases  of 
adenomyosis,  14  cases of  myomatous polyp  and 4 cases of 
endometrial polyp were missed by fractional curettage.
Out of 100 perimenopausal patients, 72 had normal endometrium both 
by  transvaginal  sonogram and histopathologic  diagnosis.  In  this  16  cases 
were followed up with transvaginal sonogram and remaining cases underwent 
hysterectomy. 12 cases with endometrial thickness greater than 15mm and 
no  other  abnormal  intracavitory,  pathology  were  found  indeed  to  have 
endometrial  hyperplasia  as  per  hysterectomy  specimen.  16  cases  of 
adenomyosis,  14  cases  of  myomatous  polyp  and  4  cases  of  endometrial  
polyp were all diagnosed by transvaginal sonogram which correlated well with 
the pathological diagnosis after hysterectomy giving a sensitivity of 92.86%, 
specificity of 100%, positive predictive value of 100% and negative predictive 
value of 97.3%.
This is compared with the following studies.
(i) March  and  Tombin  evaluated  149  consecutive  patients  with 
perimenopausal  bleeding  by  transvaginal  sonography  and  the 
findings were compared with specimen obtained from hysterectomy 
used to represent the true diagnosis. The findings after transvaginal 
sonogram  was  normal  in  59  patients,  intramural  myoma  in  52 
patients, thickened uterine wall in 11 patients and polypoid lesion in 
2 patients. The final pathological diagnosis after hysterectomy was 
hyperplasia in 6 patients, adenomyosis in 11 patients, myoma in 52 
patients, polyps in 72 patients and normal in 7 patients. It is seen 
that  myomas  and  adenomyosis  correlated  well  with  the  final 
pathological  diagnosis,  out  of  which  15 endometrial  polyps  were 
missed by transvaginal sonogram. Normal pathology was seen only 
in 7 patients all these giving a sensitivity of 54% and specificity of 
90%.  They  concluded  that  the  limiting  factor  with  transvaginal 
sonogram is the high frequency of “equivocal” scans.
(ii) Emmanual  et  al  in  their  analysis  of  279  women  with 
perimenopausal bleeding subjected to transvaginal sonogram and 
compared with final pathological diagnosis at hysterectomy. They 
found that 135 patients with normal sonogram when compared with 
final pathological diagnosis endometrial polyps were not visualised 
in 4 premenopausal patients marked by very hyperecho dense late 
secretory endometrium. These would have been visualised well, if 
carried out  during proliferative  phase.  In  54 patients  submucous 
myomas , in 5 patients endometrial hyperplasia and in 6 patients 
with endometrial carcinoma were diagnosed correctly. Transvaginal 
sonogram was in conclusive in 19 patients giving sensitivity of 96%, 
specificity of 61% and positive predictive value of 39% .
DISCUSSION
In  the  group  with  postmenopausal  bleeding  the  thickness  of 
endometrium ranged from 1.2 mm in a women with atrophic endometrium to 
18mm in a woman with well differentiated stage - I endometrial carcinoma.
The  percentage  of  carcinoma  endometrium  was  6%  and  the 
endometrial hyperplasia was 12%. In 52% of women were found to have an 
atrophic endometrium to tissue insufficient for diagnosis.
Out  of  100  women  with  normal  sized  uterus  on  examination  2 
myomatous  polyps,  4  endometrial  polyp  and  10  cases  of  pyometra  were 
diagnosed  by  ultrasonogram.  These  findings  correlated  with  pathological 
diagnosis after hysterectomy.
A  transvaginal  ultrasound  measured  endometrial  thickness  of  5mm 
and  less  was  associated  with  an  atrophic,  active  endometrium  or  tissue 
insufficient for diagnosis in the histopathological report.
Endometrial  pathology  and  abnormalities  were  found  only  among 
those women whose endometrial thickness was greater than 5 mm.
Various studies have been conducted in the last five years and the 
results of some are compared with the present study.
TABLE 1
Endometrial  thickness  is  measured  by  transvaginal  sonography  for 
identifying  endometrial  abnormality  in  women  with  postmenopausal 
bleeding. A comparison of various study groups.
Study group
No. of 
patients
Cutoff 
point 
in mm
Sensitivity 
%
Specificity 
%
PPV
%
NPV 
%
Lewin et al 50 5 100.0 64.0 - -
Kufahl et al 181 4 90.3 24.8 21.4 91.9
Curci-CA et al 35 3 93.10 66.66 - -
Wolman 54 6 89.0 83.0 - -
Conoscenti et al 149 4 95.2 96.1 68.7 93.2
Weber 159 5 94.0 48.0 69.0 87.0
Kekre et al 80 4 97.0 98.0 97.0 94.0
Present study 100 5 92.31 67.57 50.0 96.15
PPV – Positive predictive value ; NPV - Negative predictive value
The purpose of the study of Lewin et al was to evaluate endometrial  
thickness as the only parameter for excluding endometrial abnormalities. In 
this study no endometrial abnormality was found if the endometrium was less 
than 5mm thick. Out of 32 patients whose endometrial thickness was more 
than 5mm, 22 had pathological changes in the endometrium. These included 
6 cases of endometrial cancer and 16 with benign changes.
Kufahl et al in their study of 181 postmenopausal women with bleeding 
reported that endometrial thickness of less than 5mm is uniformly associated 
with minimal tissue obtained by sampling or an atrophic endometrium. They 
had one malignancy in this series. They described it as a very sensitive but 
not a very specific technique (Sensitivity of 90.3% and Specificity of 24.8%).
Curci-CA et al in their prospective study of 35 postmenopausal women 
not on hormone replacement therapy reported that an endometrium of more 
than 3mm associated with abnormality. They found vaginal sonography to be 
a  highly  specific  and  sensitive  method  for  the  detection  of  endometrial 
pathology.
Wolman et al in their analysis of 54 postmenopausal women found that 
the sensitivity of vaginal ultrasonography for endometrial disease was 89% if  
6mm was used as the cutoff point for endometrial thickness.
Conoscenti  et  al  in their  study of  149 postmenopausal  women with 
cutoff point of endometrial thickness was 4mm showed sensitivity of 95.2 and 
specificity of 96.1% for endometrial pathology.
Weber  and  Kekre  et  al  showed  similar  results  with  endometrial 
thickness between 4 to 5 mm.
GROUP A: WOMEN WITH POSTMENOPAUSAL BLEEDING
In  the  present  study  of  100  women  with  postmenopausal  bleeding 
using  5mm  as  a  cutoff  limit,  vaginal  sonography  successfully  diagnosed 
endometrial abnormality. 
The results obtained were
 Specificity of 67.57%.
 Sensitivity of 92.31%.
 Positive predictive value of 50%.
 Negative predictive value of 96.15%.
 Diagnostic accuracy of 74%.
In  100  women  with  normal  pelvic  examination,  pyometra  was 
diagnosed  in  10  cases,  polyp  was  diagnosed  in  4  cases,  Endometrial 
carcinoma was  correctly  diagnosed in  6  cases.  Here the ultrasonographic 
findings  correlated  well  with  the  pathological  report  of  the  hysterectomy 
specimen.
GROUP B: WOMEN WITH PERIMENOPAUSAL BLEEDING
In women with perimenopausal bleeding the percentage of endometrial 
carcinoma was  2%,  endometrial  hyperplasia  was  24%,  adenomyosis  was 
16%, myoma uterus was 14%, endometrial polyps was 4% and endometritis 
was 2%. Out of interest, 4 cases of endometrial biopsy was taken through 
hysteroscope.
In  100  women  with  normal  pelvic  examination  adenomyosis  was 
diagnosed in 16 cases, myoma was diagnosed in 14 cases and endometrial 
polyp diagnosed in 4 cases. Endometrial carcinoma was correctly diagnosed 
in 2 cases. The ultrasonographic findings correlated well with the pathological 
report of the hysterectomy specimen. 
The results obtained were
 Sensitivity of 92.86%.
 Specificity of 100%.
 Positive predictive value of 100%.
 Negative predictive value of 97.3%.
 Diagnostic accuracy of 98%.
In  this  study  72%  of  women  with  normal  endometrium  had  an 
endometrial  thickness  of  less  than  15mm  below  which  there  was  no 
endometrial pathology. Above this cutoff level were found to associated with 
endometrial pathology. 
TABLE 2
Endometrial  thickness  is  measured  by  transvaginal  sonography  for 
identifying  endometrial  abnormality  in  women  with  perimenopausal 
bleeding. A comparison of various study groups.
Study group
No. of 
patients
Cutoff 
point in 
mm
Sensitivity 
%
Specificity 
%
PPV
%
NPV 
%
Get Pook et al 111 8 83.9 58.8 - 90.4
Minagawa et al 125 20 100.0 99.1 92.9 100.0
Towbin March et 
al
131 15 100.0 86.0 91.7 94.0
Emmanuel et al 279 12 79.0 93.0 - -
Fleischer et al 62 15 85.0 21.0 - -
Kalantaridou 80 13 100.0 71.64 40.62 -
Present Study 100 15 92.86 100 100 97.3
PPV – Positive predictive value ; NPV - Negative predictive value
Getpook et al in a study involving 111 patients, established a sensitivity 
of 83.9% and negative predictive value of 90.4% by considering 8mm as the 
cutoff  point  beyond  which  intrauterine  pathology  and  endometrial 
abnormalities were present that is 31 (27.9%) had an abnormal endometrium 
i.e.  hyperplasia  13.5%,  polyps  5.4%,  submucous  myoma  5.4%  and 
adenocarcinoma 3.6%. 
Minagawa’s study of  131 patients,  with  a cutoff  a 15mm, yielded a 
sensitivity of 100% and a specificity of 99.1%. The histological diagnosis of 
the  endometrium  included  13  endometrial  cancers,  9  endometrial 
hyperplasias (one atypical  hyperplasia  and 3 hyperplastic  polyps),  and 10 
normal endometrium. 
Towbin, March et al had found that in their analysis of 131 patients with 
perimenopausal bleeding, a thick endometrial stripe of more than or equal to 
15mm  were  found  to  correlate  strongly  with  the  presence  of  intrauterine 
pathology and endometrial  abnormalities. Sensitivity of 100%, specificity of 
86%, positive predictive value of 91.7% and negative predictive value of 94%.
Emmanuel, Mark, et al in the year 1995 in their analysis of 279 women 
with  perimenopausal  bleeding  have  found  a  cutoff  value  of  12mm  for 
endometrial thickness below which the report was normal endometrium and 
above which it was associated with endometrial pathology.
Emmanuel et al have also stated that though in the literature, normal 
cutoff levels for premenopausal endometrial thickness were not available. He 
concluded from his  study that  such a cutoff  level  can be assigned to  the 
premenopausal  patients  for  exclusion  of  endometrial  abnormalities  as  is 
available in postmenopausal patients.
Fleischer reported a sensitivity of 85% in his study of 62 patients with 
15mm as the cutoff point for endometrial thickness.
Kalantaridou with a cutoff value of 13mm in 80 patients achieved 100% 
sensitivity.
SUMMARY
• Study consists of 200 patients, 100 patients with perimenopausal bleeding 
and 100 patients with postmenopausal bleeding.
• In women with postmenopausal bleeding, when the endometrial thickness 
less  than  or  equal  to  5mm  in  transvaginal  sonogram  the 
histopathological  report  was  atrophic  endometrium.  When  the 
endometrial  thickness was  more  than 5  mm it  was  associated with 
endometrial pathology. This yields sensitivity of 92.31%, specificity of 
67.57%, and positive predictive value of 50% and negative predictive 
value of 96.15%.
• In women with perimenopausal bleeding, when the endometrial thickness 
was  less  than  or  equal  to  15mm  in  transvaginal  sonogram,  the 
histopathological  report  was  proliferative  or  secretory  endometrium. 
When the endometrial thickness was more than or equal to 15mm the 
report  was  endometrial  hyperplasia  or  carcinoma.  This  yields 
sensitivity of 92.86%, specificity of 100%, and positive predictive value 
of 100% and negative predictive value of 97.3%.
• In  both  groups  of  women  with  perimenopausal  and  postmenopausal 
bleeding, intrauterine abnormalities of endometrium and myometrium 
as  adenomyosis,  myomatous  polyps  and  endometrial  polyps  were 
diagnosed. 
• Cases  with  endometrial  hyperplasia  and  endometrial  adenocarcinoma 
were  diagnosed  with  precision  by  transvaginal  sonogram  and 
myometrial invasion was also predicted.
• In women with perimenopausal bleeding, transvaginal sonogram picked 
up 16 cases of adenomyosis, 14 cases of myomatous polyps and 4 
cases  of  endometrial  polyps  which  were  missed  by  fractional 
curettage.
• In women with postmenopausal  bleeding transvaginal  sonogram picked 
up 2 cases of  myomatous polyps  and 4  case of  endometrial  polyp 
which were missed by fractional curettage.
CONCLUSION
Transvaginal sonogram is a simple, non-invasive convenient way to 
indirectly visualize the endometrial cavity.
The vaginal  probe examination if  incorporated into  the gynaecology 
office  setting  and  when  combined  with  bimanual  pelvic  examination  can 
enhance our anatomic diagnosis.
Transvaginal sonography is useful as a first step diagnostic procedure 
in the evaluation of perimenopausal and postmenopausal bleeding.
When  combined  with  fractional  curettage  it  can  supplement  the 
shortcomings of fractional curettage.
This  study  proves  that  this  diagnostic  tool  correlates  well  with  the 
histopathology findings.
Intrauterine pathology of the endometrium and myometrium were well  
preciously  delineated  and  endometrial  hyperplasia  and  endometrial 
carcinoma  could  be  detected.  It  can  also  find  out  associated  ovarian 
pathology.
In future it appears that the ultrasonogram will continue to take the role 
of a stethoscope for the gynaecologist, to see the lining of the uterine cavity 
and the information obtained seems worthwhile.
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PROFORMA
Measurement  of  endometrial  thickness  in  women  with  peri  and  post 
menopausal bleeding and its correlation with histopathology.
Name : Age : I.P. No. :
D.O.A. : Residence
D.O.D. :
C/o. : Bleeding pv or
discharge pv.
HISTORY OF PRESENT ILLNESS
Bleeding pv since
Profuse/Moderate/scanty
H/o of passing clots
Discharge pv since.
Menstrual H/o
Age of menarche
Menstrual cycle regular/irregular
/days
Profuse/Moderate/Scanty
Dysmenorrhoea Present/Absent
Inter menstrual bleeding
Date of L.M.P.
Menopause Attained/Not attained
Years
Treatment H/o 
Earlier contraceptive history
Oral contraceptive Pills
Intra uterine contraceptive device
Hormone replacement therapy
Obstetrical H/o
Married life Parity Living children
Last child birth Sterilisation
Past History H/o Tuberculosis
H/o Diabetes mellitus
H/o Hypertension
H/o Bleeding disorders
H/o Any D & C in the past
H/o Any surgery
Family History
Tuberculosis Hypertension
Diabetes Mellitus Carcinoma
Personal History
Obesity Diet Sleep Micturition
Appetite Bowel
Physical Examination
General condition Build
Nourishment Temperature
Pulse Rate B.P.
Pallor Teeth
Gums Thyroid
Jaundice Neck veins
Oedema
Lymph nodes
Per Abdomen
Vaginal Examination
Inspection of vulva
Palpation of external genitalia
P/s Vagina
Cervix
P/v Cervix Position Discharge
Uterus Position Size Mobile/Restricted
Fornices
Investigations
Blood Group and Rh
Hemogram
Blood urea
Serum creatinine
Blood sugar (Random)
Urine analysis
Bleeding time
Clotting time
Pap smear
Vaginal Sonography
Uterus
Endometrial thickness
Endometrial volume
Cervix
(R) Ovary
(L) Ovary
Ovarian volume (R)
(L)
Any other abnormalities
Diagnosis
Remarks
Dilation & Curettage
Endocervical curettings
Uterine cavity sounded upto
Regular / Irregular
Technical difficulty
Specimen amount
Biopsy cervix
Hysterectomy
Histopathology report
